price
VI
NASDAQ · VIR
Vir Biotechnology, Inc.
Healthcare · Biotechnology
$9.78
Up+$0.57 (+6.19%)
Updated Aug 22, 2026, 6:11 AM
SID Score
5.8/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 923.02M
- P/E ratio
- -1.67
- Dividend yield
- 0.00%
- 52-week range
- $4.75 – $11.66
- Volume
- 1.76M
- Avg. volume
- 1.53M
Price performance
VIR price history
1M range · 21 trading sessions · Daily adjusted prices
VIR closed at $9.78 after 21 trading sessions, up 12.54% for the selected period.
- Last close
- $9.78
- Period change
- +12.54%
- Period low
- $8.64
- Period high
- $9.78
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Aug 21, 2026 | $9.31 | $9.86 | $9.305 | $9.78 | 1.76M |
| Aug 20, 2026 | $9.61 | $9.71 | $9.025 | $9.21 | 1.06M |
| Aug 19, 2026 | $9.86 | $10.08 | $9.54 | $9.77 | 2.09M |
| Aug 18, 2026 | $9.27 | $9.50 | $9.24 | $9.49 | 1.48M |
| Aug 17, 2026 | $9.23 | $9.49 | $9.17 | $9.39 | 1.46M |
| Aug 14, 2026 | $9.00 | $9.27 | $8.80 | $9.24 | 1.02M |
| Aug 13, 2026 | $9.02 | $9.20 | $8.8828 | $9.00 | 1.25M |
| Aug 12, 2026 | $8.89 | $9.09 | $8.855 | $8.96 | 984.21K |
| Aug 11, 2026 | $8.96 | $9.01 | $8.771 | $8.93 | 1.2M |
| Aug 10, 2026 | $8.80 | $9.03 | $8.79 | $8.89 | 1.49M |
| Aug 7, 2026 | $8.87 | $9.03 | $8.75 | $8.82 | 1.66M |
| Aug 6, 2026 | $9.699 | $9.699 | $8.615 | $8.765 | 2.6M |
| Aug 5, 2026 | $9.19 | $9.36 | $9.00 | $9.11 | 1.45M |
| Aug 4, 2026 | $9.02 | $9.275 | $8.93 | $9.17 | 1.71M |
| Aug 3, 2026 | $8.91 | $9.06 | $8.545 | $8.90 | 1.24M |
| Jul 31, 2026 | $8.95 | $8.96 | $8.535 | $8.66 | 1.13M |
| Jul 30, 2026 | $8.61 | $8.995 | $8.61 | $8.90 | 1.2M |
| Jul 29, 2026 | $8.84 | $8.97 | $8.55 | $8.64 | 1.41M |
| Jul 28, 2026 | $8.83 | $8.885 | $8.52 | $8.85 | 1.39M |
| Jul 27, 2026 | $8.82 | $9.085 | $8.77 | $8.80 | 1.69M |
| Jul 24, 2026 | $9.00 | $9.15 | $8.62 | $8.69 | 2.15M |
Latest VIR news
The latest Smart Investors Daily articles mentioning VIR.
Stock researchResearch & News · SEC Filings
Loading stock research…

